BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8032223)

  • 1. The biology of meningiomas.
    Smith DA; Cahill DW
    Neurosurg Clin N Am; 1994 Apr; 5(2):201-15. PubMed ID: 8032223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptors and their role in the biology and control of breast cancer growth.
    Cordera F; Jordan VC
    Semin Oncol; 2006 Dec; 33(6):631-41. PubMed ID: 17145341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of meningiomas: from basic research to potential clinical applications.
    Simon M; Boström JP; Hartmann C
    Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor expression in meningiomas.
    Carroll RS; Glowacka D; Dashner K; Black PM
    Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the new biology for therapy in breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormone binding and peritumoural oedema in meningiomas: is there a correlation?
    Meixensberger J; Caffier H; Naumann M; Hofmann E
    Acta Neurochir (Wien); 1992; 115(3-4):98-102. PubMed ID: 1605091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiology of tumours and head injury, and the neuroimmunology of central nervous system malignancy.
    Ironside JW
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):16-21. PubMed ID: 1320434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas.
    Carroll RS; Brown M; Zhang J; DiRenzo J; Font De Mora J; Black PM
    Clin Cancer Res; 2000 Sep; 6(9):3570-5. PubMed ID: 10999746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cistromics of hormone-dependent cancer.
    Lupien M; Brown M
    Endocr Relat Cancer; 2009 Jun; 16(2):381-9. PubMed ID: 19369485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.
    Doane AS; Danso M; Lal P; Donaton M; Zhang L; Hudis C; Gerald WL
    Oncogene; 2006 Jun; 25(28):3994-4008. PubMed ID: 16491124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of progesterone receptor status in meningiomas.
    Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
    J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.